FDA approves treatment for two rare diseases
On May 6, the FDA approved Ruzurgi (amifampridine) tablets for the treatment of Lambert-Eaton myasthenic syndrome in patients 6 to…
Please share your feedback! We’re interested to learn more about your experience with American Nurse Journal.